S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates

Quest Diagnostics (DGX) Earnings Date, Estimates & Call Transcripts

$130.02
-1.60 (-1.22%)
(As of 04/11/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 23
Before Market Opens
Confirmed
Actual EPS
(Feb. 1)
$2.15 Beat By $0.04
Consensus EPS
(Feb. 1)
$2.11
Skip Charts & View Estimated and Actual Earnings Data

DGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Quest Diagnostics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$1.84$2.17$1.96 
Q2 20243$2.28$2.29$2.29 
Q3 20243$2.26$2.35$2.30 
Q4 20243$2.22$2.32$2.28 
FY 202412$8.60$9.13$8.83 
Q1 20251$2.26$2.26$2.26 
Q2 20251$2.34$2.34$2.34 
Q3 20251$2.31$2.31$2.31 
Q4 20251$2.33$2.33$2.33 
FY 20254$9.24$9.24 $9.24

DGX Earnings Date and Information

Quest Diagnostics last released its earnings data on February 1st, 2024. The medical research company reported $2.15 EPS for the quarter, beating the consensus estimate of $2.11 by $0.04. The business had revenue of $2.29 billion for the quarter, compared to analysts' expectations of $2.25 billion. Its quarterly revenue was down 1.9% on a year-over-year basis. Quest Diagnostics has generated $7.49 earnings per share over the last year ($7.49 diluted earnings per share) and currently has a price-to-earnings ratio of 17.4. Earnings for Quest Diagnostics are expected to grow by 7.43% in the coming year, from $8.75 to $9.40 per share. Quest Diagnostics has confirmed that its next quarterly earnings report will be published on Tuesday, April 23rd, 2024. Quest Diagnostics will be holding an earnings conference call on Tuesday, April 23rd at 8:30 AM Eastern. Interested parties can register for or listen to the call. or dial in at 203-369-0197.

Quest Diagnostics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/23/2024
Confirmed)
-------  
2/1/2024Q4 2023$2.11$2.15+$0.04$2.60$2.25 billion$2.29 billion    
10/24/2023Q3 2023$2.19$2.22+$0.03$2.48$2.27 billion$2.30 billion      
7/26/2023Q2 2023$2.23$2.30+$0.07$2.55$2.25 billion$2.34 billion    
4/27/2023Q1 2023$1.97$2.04+$0.07$2.30$2.20 billion$2.33 billion      
2/2/2023Q4 2022$1.90$1.98+$0.08$3.09$2.26 billion$2.33 billion    
10/20/2022Q3 2022$2.17$2.36+$0.19$2.55$2.34 billion$2.49 billion      
7/21/2022Q2 2022$2.26$2.36+$0.10$2.76$2.34 billion$2.45 billion      
4/21/2022Q1 2022$2.91$3.22+$0.31$3.52$2.64 billion$2.61 billion    
2/3/2022Q4 2021$3.35$3.33($0.02)$3.54$2.66 billion$2.74 billion    
10/20/2021Q3 2021$2.88$3.96+$1.08$3.90$2.52 billion$2.77 billion    
7/22/2021Q2 2021$2.87$3.18+$0.31$1.40$2.38 billion$2.55 billion    
4/22/2021Q1 2021$3.77$3.76($0.01)$4.06$2.66 billion$2.72 billion  

Quest Diagnostics Earnings - Frequently Asked Questions

When is Quest Diagnostics's earnings date?

Quest Diagnostics has confirmed that its next quarterly earnings data will be published on Tuesday, April 23rd, 2024. Learn more on DGX's earnings history.

Did Quest Diagnostics beat their earnings estimates last quarter?

In the previous quarter, Quest Diagnostics (NYSE:DGX) reported $2.15 earnings per share (EPS) to beat the analysts' consensus estimate of $2.11 by $0.04. Learn more on analysts' earnings estimate vs. DGX's actual earnings.

How can I listen to Quest Diagnostics's earnings conference call?

The conference call for Quest Diagnostics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Quest Diagnostics's conference call transcript?

The conference call transcript for Quest Diagnostics's latest earnings report can be read online. Read Transcript

How much revenue does Quest Diagnostics generate each year?

Quest Diagnostics (NYSE:DGX) has a recorded annual revenue of $9.25 billion.

How much profit does Quest Diagnostics generate each year?

Quest Diagnostics (NYSE:DGX) has a recorded net income of $854 million. DGX has generated $7.49 earnings per share over the last four quarters.

What is Quest Diagnostics's price-to-earnings ratio?

Quest Diagnostics (NYSE:DGX) has a trailing price-to-earnings ratio of 17.36 and a forward price-to-earnings ratio of 14.86. The price/earnings-to-growth ratio is 2.81.

What is Quest Diagnostics's EPS forecast for next year?

Quest Diagnostics's earnings are expected to grow from $8.75 per share to $9.40 per share in the next year, which is a 7.43% increase.


More Earnings Resources from MarketBeat

This page (NYSE:DGX) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners